You are here

Calliditas

Calliditas' liver disease trial hits primary endpoint after sweeping changes to design

Fierce Biotech

Fri, 07/26/24 - 11:08 am

primary biliary cholangitis

clinical trials

Alnylam clears phase 2 test for Regeneron-partnered nephropathy med, as it looks to play catch-up against Calliditas

Fierce Biotech

Tue, 08/30/22 - 11:48 am

immunoglobin A nephropathy

clinical trials

Go or no go? Argenx's December showdown

EP Vantage

Wed, 12/1/21 - 10:10 am

myasthenia gravis

Not so fast: FDA tacks 3 more months onto decision date for Calliditas' rare kidney disorder drug

Endpoints

Wed, 09/15/21 - 10:09 pm

Several months after rebranding, an old Martin Skhreli company touts promising pivotal data in a rare kidney disorder

Endpoints

Mon, 08/16/21 - 12:12 pm

Travere Therapeutics

Calliditas is Getting to the Heart of Berger’s Disease

BioSpace

Thu, 06/3/21 - 12:05 am

IgA nephropathy

Berger's disease

FDA sets September review date for Calliditas’ rare kidney disease drug

Pharmaforum

Thu, 04/29/21 - 10:26 am

primary IgA nephropathy

With industry's growing kidney moment, Everest begins building kidney portfolio

BioCentury

Mon, 06/10/19 - 09:29 am

Everest Medicines

clinical trials

IgA nephropathy